Related Experiment Video
Updated: Jun 12, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Mitotic drug targets
Phillip Kaestner1, Holger Bastians
1Institute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Emil-Mannkopff-Strasse 2, D-35037 Marburg, Germany.
Journal of Cellular Biochemistry
|June 3, 2010
Summary
Targeting mitosis, the process of cell division, offers a promising anti-cancer strategy. This review explores novel drug targets beyond microtubules to improve chemotherapy efficacy and reduce side effects.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Mitosis is crucial for cell division, and disrupting it is a validated anti-cancer strategy.
- Current microtubule-targeting drugs are effective but cause severe side effects due to targeting all proliferating cells.
- There is a growing need for novel mitotic drug targets to enhance cancer therapy.
Purpose of the Study:
- To review recent advancements in identifying and clinically evaluating new mitotic drug targets.
- To introduce innovative chemotherapy concepts based on a deeper understanding of mitotic regulation.
- To explore how anti-mitotic drugs induce tumor cell death.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of clinical trial data for novel mitotic agents.
- Synthesis of current knowledge on mitotic pathway regulation.
Main Results:
- Several novel mitotic drug targets beyond microtubules are under investigation.
- New therapeutic strategies aim to selectively target cancer cells, minimizing side effects.
- Understanding mitotic regulation is key to developing more effective anti-cancer drugs.
Conclusions:
- Novel mitotic targets offer potential for more selective and effective cancer therapies.
- Further research into mitotic regulation can lead to improved chemotherapy regimens.
- Developing anti-mitotic drugs with reduced toxicity is a critical goal in oncology.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
01:45Destabilization of Microtubules
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...